Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
BVXV

Overview Financials Analysis Smart Money

BiondVax Pharmaceuticals Ltd.

BVXV · NASDAQ

Analyze with AI

Filings1

Total reported value$1.8K

Manager	Shares	Value	Change
NEXT Financial Group, Inc	1.4K	$1.8K	0.0%

SymbolBVXV

Market Cap$5.0M

IPO Date2015-05-12

CEOAmir Reichman

Employees33

SectorHealthcare

IndustryBiotechnology

CountryIL

ExchangeNASDAQ Capital Market

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

GD Culture Group Limited

GDC

$5.26

+51.59%

Peers

Neuphoria Therapeutics Inc.

NEUP · NASDAQ

$3.89

+0.00%

Tectonic Therapeutic, Inc.

TECX · NASDAQ

$19.56

+6.48%

Nabriva Therapeutics plc

NBRVF · OTC

$0.0001

+0.00%

Fresh Tracks Therapeutics, Inc.

FRTX · NASDAQ

$0.935

-0.53%

Gamida Cell Ltd.

GMDA · NASDAQ

$0.0327

+0.00%

TNF Pharmaceuticals, Inc.

TNFA · NASDAQ

$5.20

+48.15%

Aptose Biosciences Inc.

APTO · NASDAQ

$1.71

+100.00%

Hillstream BioPharma, Inc.

HILS · NASDAQ

$0.237

+5.66%

Tricida, Inc.

TCDA · NASDAQ

$0.108

+0.00%

Altamira Therapeutics Ltd.

CYTO · NASDAQ

$0.30

+100.00%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.